Inactive Instrument
Bellicum Pharmaceuticals, Inc. Stock OTC Markets
Stocks
BLCM
US0794814048
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 1.76M 1.56M 1.47M 1.34M 2.51M 169M 2.53M 17.68M 6.81M 86.48M 6.63M 6.48M 278M | P/E 2021 |
-1.77x | P/E 2022 | -0.89x |
|---|---|---|---|---|---|
| Enterprise Value | -20.07M -17.71M -16.76M -15.2M -28.5M -1.93B -28.78M -201M -77.49M -984M -75.37M -73.73M -3.17B | EV / Sales 2021 |
-5.43x | EV / Sales 2022 | -10.4x |
| Free-Float |
98.45% | Yield 2021 * |
-
| Yield 2022 | - |
| 1 day | -6.68% |
| Manager | Title | Age | Since |
|---|---|---|---|
Dave Maggio
CEO | Chief Executive Officer | 66 | 23/02/2024 |
Richard Fair
CEO | Chief Executive Officer | 57 | 31/01/2017 |
| Director | Title | Age | Since |
|---|---|---|---|
Richard Fair
BRD | Director/Board Member | 57 | - |
Judith Kilmovsky
BRD | Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -6.68% | -18.17% | - | - | 822K | |
| -0.70% | -4.28% | +52.62% | +86.42% | 71.81B | |
| +0.45% | -0.82% | +38.81% | +84.19% | 60.06B | |
| +2.43% | +3.60% | +33.48% | +23.06% | 27.93B | |
| -1.73% | -4.30% | -18.37% | +357.94% | 25.7B | |
| -0.51% | -2.28% | +0.48% | -9.27% | 24.89B | |
| +0.65% | +1.67% | +26.47% | -7.62% | 20.92B | |
| +3.46% | +3.02% | +158.90% | +337.81% | 15.04B | |
| +0.48% | +0.86% | +44.56% | +168.42% | 14.46B | |
| +0.34% | -1.74% | -7.67% | +503.82% | 13.87B | |
| Average | -0.20% | -1.38% | +36.59% | +171.64% | 30.52B | |
| Weighted average by Cap. | +0.22% | -1.84% | +36.65% | +128.22% |
| 2021 | 2022 | |
|---|---|---|
| Net sales | 6.2M 5.47M 5.18M 4.69M 8.8M 595M 8.89M 62.1M 23.94M 304M 23.28M 22.77M 978M | 1.5M 1.32M 1.25M 1.14M 2.13M 144M 2.15M 15.03M 5.79M 73.5M 5.63M 5.51M 237M |
| Net income | -9.7M -8.56M -8.1M -7.35M -13.78M -931M -13.91M -97.21M -37.47M -476M -36.44M -35.65M -1.53B | -24.97M -22.04M -20.85M -18.91M -35.45M -2.4B -35.8M -250M -96.41M -1.22B -93.77M -91.73M -3.94B |
| Net Debt | -46.16M -40.73M -38.54M -34.95M -65.53M -4.43B -66.17M -462M -178M -2.26B -173M -170M -7.28B | -21.84M -19.27M -18.23M -16.54M -31M -2.1B -31.31M -219M -84.3M -1.07B -82M -80.21M -3.44B |
Employees
13
